See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot4,012▼ 0.30%WTI103.27▲ 3.82%
← VMX page
XStocksXray
Market X-Ray report · 23 October 2026

Verimatrix (VMX)

Euronext Paris · France · prices in EUR · close of 23 Oct 2026

Key indicators

Last closeEUR 0.245
52-week range0.144 – 0.377
Return, 1 month / 3 months−19.7% / +17.8%
Return, 1 year / 3 years+34.6% / −42.6%
TrendAbove 200-day, below 50-day
RSI (14)25
Volatility (1 year)56.7%
Worst drawdown (1 year)-33.8%
Average daily value traded0.05M EUR
Dividend yield–

Market X-Ray price-based

68/ 100 · High confidence · ahead of 80% of stocks on this exchange
Trend76
Momentum94
Stability (higher is calmer)43
Liquidity56
Income–

Five-year price chart navy: price · brown: 200-day average

0.070.410.741.081.412021-112023-022024-052025-082026-10

About the company

Verimatrix is a software company that supplies security technology for video services and connected devices. It provides conditional access, digital rights management and watermarking tools that help pay-television operators, streaming providers and device makers protect content and manage how it is delivered to viewers. The company is based in France and works with customers around the world who distribute television and video over broadcast, internet and mobile networks.

Verimatrix trades under the code VMX on the Euronext Paris in France, with its price quoted in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Verimatrix (VMX) trades on the Euronext Paris in France. It last closed at EUR 0.245 on 23 October 2026.

Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 123 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 34.6% and over the last three months it rose 17.8%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Verimatrix (VMX)

The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris

Lens and metricValueScoreReading
Trend76 · StrongTrading above its long-term averages and near its highs.
Above 200-day average7.0%
From 52-week high-33.8%
Momentum94 · StrongRising faster than most stocks on this exchange.
3-month return17.8%
6-month return42.4%
12-month return, skipping the last month67.6%
Stability (higher is calmer)43 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)56.7%
Worst drawdown, 1 year (smaller is calmer)-33.8%
Liquidity56 · FairModerate trading activity.
Average daily value traded0.05M EUR
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−12.2%
1 month−19.7%
3 months+17.8%
6 months+42.4%
1 year+34.6%
3 years−42.6%
5 years−80.9%

Signals

50-day / 200-day average0.315 / 0.229
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.011

Technical summary

DailyBearish5 bullish · 0 neutral · 11 bearish
WeeklyBearish4 bullish · 1 neutral · 7 bearish
MonthlyNeutral3 bullish · 1 neutral · 4 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 24 Oct 2026